Delivery Order SPE2DB22D1103-SPE2DB24FTEH4
- Not listed
- This federal contract award is for the delivery of Trelegy Ellipta 100-62.5-25 60S pharmaceutical products to the Defense Logistics Agency (DLA). The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor, and has a ceiling value of $10,800.64. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support...
- This federal contract award is for the delivery of Trelegy Ellipta 100-62.5-25 prescription medications to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $11,216.89 and an ultimate completion date of March 7, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. The award was made on March 6, 2024, and there is no set-aside designation....
- The federal contract award is for the pharmaceutical product Trelegy Ellipta, awarded by the Defense Logistics Agency (DLA) to the prime contractor AmerisourceBergen Drug Corp. The contract has a ceiling value of $2,720.73 and is a firm fixed price delivery order with a completion date of March 5, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that specializes in supplying medical products...
- This federal contract award is for the pharmaceutical product Trelegy Ellipta 100-62.5-25 60S. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a ceiling value of $34,752.16. It is a delivery order contract with a firm fixed price pricing type. The contract does not have a...
- This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to supply Trelegy Ellipta 100-62.5-25 60S to the Defense Logistics Agency (DLA). The contract has a ceiling value of $23,865.25 and is a firm fixed price delivery order. It has an ultimate completion date of July 16, 2025. The contract is not set aside and is open to full and open competition. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery...
- This federal contract award is for the pharmaceutical product Trelegy Ellipta 100-62.5-25 60S, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,176.39 firm fixed-price delivery order contract has a completion date of January 7, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award is for the delivery of TRELEGY ELLIPTA 100-62.5-25 60S pharmaceutical products to the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $3,664.58 and a performance period ending on December 4, 2023. It is a firm fixed-price delivery order contract with no set-aside designation,...
- This federal contract award is for the delivery of TRELEGY ELLIPTA 200-62.5-25 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The award was made to the Amerisourcebergen Drug Corp, a major pharmaceutical supplier to the U.S. government. The contract has a ceiling value of $24,971.49 and is a Firm Fixed Price Delivery Order that will be completed by April 24, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award is for the pharmaceutical product TRELEGY ELLIPTA 100-62.5-25 60S, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $27,791.08 and is a Firm Fixed Price Delivery Order, with a completion date of February 26, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
- This federal contract award is for the delivery of TRELEGY ELLIPTA 100-62.5-25 60S pharmaceutical products to the Defense Logistics Agency (DLA). The $3,739.42 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive...
- SPE2DB22D1103Indefinite Delivery Contract
- SPE2DB22D1103-SPE2DB24FTEH4Delivery Order
This federal contract award is for the delivery of Trelegy Ellipta pharmaceutical products to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor, which is a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $5,243.57 and runs through January 26, 2024. It is a firm-fixed-price delivery order contract, with no set-aside designation. Amerisourcebergen Drug Corp also holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.2k | 1/25/24 |